IL-10 plus the EASIX score predict bleeding events after anti-CD19 CAR T-cell therapy

Chimeric antigen receptor (CAR) T-cell-associated coagulopathy can cause bleeding events. To explore risk factors for hemorrhage after CAR T-cell therapy, we retrospectively analyzed routine indicators in 56 patients with non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia who received anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xindi, Li, Chenggong, Luo, Wenjing, Zhang, Yinqiang, Huang, Zhongpei, Xu, Jia, Mei, Heng, Hu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640490/
https://www.ncbi.nlm.nih.gov/pubmed/37814134
http://dx.doi.org/10.1007/s00277-023-05477-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640490/
https://www.ncbi.nlm.nih.gov/pubmed/37814134
http://dx.doi.org/10.1007/s00277-023-05477-y

Ejemplares similares